Last updated: 8 March 2024 at 6:00pm EST

R. David Hoover Net Worth

The estimated Net Worth of R David Hoover is at least $8.85 millió dollars as of 6 March 2024. Mr. Hoover owns over 20,000 units of Elanco Animal Health Inc stock worth over $2,678,800 and over the last 15 years he sold ELAN stock worth over $5,719,404. In addition, he makes $456,006 as Independent Chairman of the Board at Elanco Animal Health Inc.

Mr. Hoover ELAN stock SEC Form 4 insiders trading

R has made over 90 trades of the Elanco Animal Health Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of ELAN stock worth $322,800 on 6 March 2024.

The largest trade he's ever made was exercising 240,000 units of Elanco Animal Health Inc stock on 14 March 2016 worth over $5,244,000. On average, R trades about 12,583 units every 22 days since 2009. As of 6 March 2024 he still owns at least 185,000 units of Elanco Animal Health Inc stock.

You can see the complete history of Mr. Hoover stock trades at the bottom of the page.

R. David Hoover biography

R. David Hoover is Independent Chairman of the Board of the Company. Mr. Hoover has served as the chairman of the Board since May 2018. Mr. Hoover has been retired since 2013. Prior to that, Mr. Hoover served in various roles at Ball Corporation, a company supplying innovative, sustainable packaging solutions and other technologies and services, including Chairman from 2002 to 2013, Chief Executive Officer from 2010 to 2011, President and Chief Executive Officer from 2001 to 2010, Chief Operating Officer from 2000 to 2001 and Chief Financial Officer from 1998 to 2000. Mr. Hoover currently serves on the board of directors of Edgewell Personal Care Company and has previously served on the board of directors of Ball Corporation and of Lilly. Mr. Hoover’s experience described above, including his extensive management experience as Chief Executive Officer and Chief Financial Officer at Ball Corporation and corporate governance experience through his service on other public boards, including nine years he previously served as a director for Lilly, provides him with the qualifications and skills to serve as a director on Elanco’s Board.

What is the salary of R Hoover?

As the Independent Chairman of the Board of Elanco Animal Health Inc, the total compensation of R Hoover at Elanco Animal Health Inc is $456,006. There are 8 executives at Elanco Animal Health Inc getting paid more, with Jeffrey Simmons having the highest compensation of $15,801,800.

How old is R Hoover?

R Hoover is 74, he's been the Independent Chairman of the Board of Elanco Animal Health Inc since 2018. There are no older and 28 younger executives at Elanco Animal Health Inc.

What's R Hoover's mailing address?

R's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.

Insiders trading at Elanco Animal Health Inc

Over the last 6 years, insiders at Elanco Animal Health Inc have traded over $1,626,280,000 worth of Elanco Animal Health Inc stock and bought 657,104 units worth $14,225,149 . The most active insiders traders include Aktiengesellschaft Bayer Wo..., Scott D.Sachem Head Capital... és R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of $14,011,833. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth $51,975.

What does Elanco Animal Health Inc do?

elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.

Complete history of Mr. Hoover stock trades at Ball, Lilly(Eli) & Co, Edgewell Personal Care Co és Elanco Animal Health Inc

Az érdekelt	Trans. Tranzakció	Teljes ár
R David Hoover	Megvenni	$322,800 6 Mar 2024
R David Hoover	Megvenni	$95,000 13 Mar 2023
R David Hoover	Megvenni	$111,300 3 Mar 2023
R David Hoover	Megvenni	$303,600 9 Sep 2022
R David Hoover	Megvenni	$233,300 20 May 2022
R David Hoover	Megvenni	$288,300 28 Feb 2022
R David Hoover	Megvenni	$293,800 30 Nov 2021
R David Hoover	Megvenni	$158,950 15 Nov 2021
R David Hoover	Megvenni	$313,100 13 Aug 2021
R David Hoover	Megvenni	$811,000 11 May 2021
R David Hoover	Megvenni	$284,300 27 Aug 2020
R David Hoover	Megvenni	$269,400 21 Aug 2020
R David Hoover	Megvenni	$263,640 13 Mar 2020
R David Hoover	Megvenni	$217,520 28 Feb 2020
R David Hoover	Megvenni	$404,400 22 Aug 2019
R David Hoover	Megvenni	$628,600 13 Mar 2019
R David Hoover	Megvenni	$240,000 24 Sep 2018
R David Hoover Rendező	Opció Gyakorlat	$691,021 3 Feb 2021
R David Hoover Rendező	Megvenni	$306,900 8 Aug 2019
R David Hoover Rendező	Megvenni	$494,550 13 May 2019
R David Hoover Rendező	Opció Gyakorlat	$102,522 9 Jul 2018
R David Hoover Rendező	Megvenni	$52,940 6 Mar 2018
R David Hoover Rendező	Megvenni	$54,780 15 Feb 2018
R David Hoover Rendező	Opció Gyakorlat	$67,538 4 Jan 2016
R David Hoover Rendező	Opció Gyakorlat	$67,538 4 Jan 2016
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$2,506,000 15 Mar 2018
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$2,378,194 14 Mar 2018
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$2,561,132 7 Mar 2018
R David Hoover Elnök és C.E.O. BALL CORP.	Eladás	$320,160 23 May 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Eladás	$402,200 22 May 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Eladás	$874,500 18 May 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$3,378,420 13 Mar 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$3,378,420 13 Mar 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$1,356,300 10 Mar 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$1,356,300 10 Mar 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$3,578,702 8 Mar 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$3,578,702 8 Mar 2017
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$616,500 8 Nov 2016
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$73,980 17 Aug 2016
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$5,244,000 14 Mar 2016
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$1,629,340 19 Mar 2015
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$1,629,340 16 Sep 2014
R David Hoover Elnök és C.E.O. BALL CORP.	Eladás	$1,228,864 12 May 2014
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$879,654 4 Mar 2013
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$4,845,566 8 Feb 2013
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$704,000 3 Dec 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Eladás	$2,235,000 30 Nov 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$492,800 12 Sep 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$178,050 2 Apr 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$296,750 15 Mar 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$296,750 1 Mar 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$296,750 16 Feb 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$5,337,348 10 Feb 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$439,190 31 Jan 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$142,440 26 Jan 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$142,440 19 Jan 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$296,750 17 Jan 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$130,570 6 Jan 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$415,450 3 Jan 2012
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$178,050 27 Dec 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$356,100 27 Oct 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$178,050 31 Aug 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$94,960 9 Aug 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$94,960 29 Jul 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$94,960 19 Jul 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$118,700 7 Jul 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$332,360 1 Jul 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Eladás	$216,120 24 Feb 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Eladás	$442,560 16 Feb 2011
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$185,675 15 Dec 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$185,675 1 Dec 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$185,675 16 Nov 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$185,675 1 Nov 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$185,675 18 Oct 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$185,675 1 Oct 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$185,675 15 Sep 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$185,675 1 Sep 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 16 Aug 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 2 Aug 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 16 Jul 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 1 Jul 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 15 Jun 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 2 Jun 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 17 May 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 3 May 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 16 Apr 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$159,150 1 Apr 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$106,100 22 Mar 2010
R David Hoover Elnök és C.E.O. BALL CORP.	Opció Gyakorlat	$55,913 2 Mar 2010
R David Hoover Rendező	Megvenni	$35,925 16 Dec 2016

Elanco Animal Health Inc executives and stock owners

Elanco Animal Health Inc executives and other stock owners filed with the SEC include:

Jeffrey Simmons,
President, Chief Executive Officer, Director
Sarena Lin,
Executive Vice President, Global Marketing, Corporate Strategy and Transformation
David Kinard,
Executive Vice President of Human Resources
David Urbanek,
Executive Vice President - Manufacturing, Quality
Aaron Schacht,
Executive Vice President - Innovation, Regulatory, Business Development
Todd Young,
Chief Financial Officer, Executive Vice President
Jeffrey N. Simmons,
Pres, CEO & Director
Todd S. Young,
Exec. VP of Corp. Governance and Strategy & CFO
R. David Hoover,
Independent Chairman of the Board
Kapila Anand,
Independent Director
Lawrence Kurzius,
Independent Director
Michael Harrington,
Independent Director
John Bilbrey,
Independent Director
Denise Scots-Knight,
Independent Director
Kirk McDonald,
Independent Director
Deborah Kochevar,
Independent Director
Art Garcia,
Independent Director
Joshua Smiley,
Independent Director
Aarti Shah,
Independent Director
David Ricks,
Independent Director
Carl McMillian,
Independent Director
James Meer,
Chief Accounting Officer, Vice President
Ramiro Cabral,
Executive Vice President - Elanco International
Michael-Bryant Hicks,
Executive Vice President, General Counsel, Corporate Secretary
Larbi Van Lier,
Sr. VP of Asia
Shawn McKee,
Sr. VP of U.S. Companion Animal
David Alan Urbanek,
Exec. VP of Manufacturing & Quality
Ramiro Martin Cabral,
Exec. VP of Elanco International
Racquel Harris Mason,
Exec. VP & Chief Marketing Officer
Marcela A. Kirberger,
Exec. VP, Gen. Counsel & Corp. Sec.
Tiffany Ann Kanaga,
Head of Investor Relations
David S. Kinard,
Exec. VP of HR Corp. Affairs & Admin.
Chris Keeley,
Sr. VP & Chief Information Officer
James M. Meer,
VP & Chief Accounting Officer
De Simas Jose Manuel Correia,
SEE REMARKS
Lilly & Co Eli,
10% owner
Timothy J Bettington,
SEE REMARKS
Aktiengesellschaft Bayer Wo...,
Racquel Harris Mason,
See Remarks
Dirk Ehle,
Ex VP & Pres Elanco Europe
Joyce J. Lee,
Ex VP Prs US Pet Hlth Com Op
Rajeev A. Modi,
SEE REMARKS
Paul Herendeen,
Marcela A. Kirberger,
SEE REMARKS
William F Doyle,
Scott D.Sachem Head Capital...,
Brabander Ellen De,
SEE REMARKS
Shiv O'neill,
GC AND CORP SEC
Grace Mc Ardle,
EVP, MANUFACTURING AND QUALITY